filmov
tv
Debate: Induction therapy for multiple myeloma - Based on an IMiD and a proteasome inhibitor
Показать описание
In this presentation from the 2017 Great Debates & Updates in Hematologic Malignancies, Dr. Paul G. Richardson argues that induction therapy for multiple myeloma should be based on an IMiD and a proteasome inhibitor.
© 2017 Imedex, LLC.
© 2017 Imedex, LLC.
0:12:54
0:13:17
0:13:37
0:13:36
0:17:31
0:16:14
0:06:20
0:11:06
0:13:58
0:09:19
0:06:06
0:01:02
0:05:06
0:21:29
0:11:38
0:08:00
0:14:37
0:05:28
0:14:34
0:22:21
0:07:54
0:01:03
0:15:58
0:16:22